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Abstract
Background: Effective protocols for the isolation and de-isolation of patients with suspected pulmonary tuberculosis
(PTB) are essential determinants of health-care costs. Early de-isolation needs to be balanced with the need to prevent
nosocomial transmission of PTB. The aim of our study was to evaluate the efficiency of our hospital’s current protocol
for isolating and de-isolating patients with suspected PTB, in particular assessing the timeliness to de-isolation of
patients with AFB smear negative respiratory samples.
Methods: We retrospectively reviewed 121 patients with suspected PTB who were admitted to our hospital’s isolation
ward. We analyzed the time spent in isolation, the total number of respiratory samples that were collected for each
patient and the time taken from collection of the first respiratory sample to release of the result of third respiratory
sample for acid-fast bacilli (AFB) smear. We also calculated the direct cost of isolation for each patient.
Results: The mean and median number of AFB smears for each patient was three. Thirty percent of patients had four
or more AFB smears taken and 20% were de-isolated before the results of three negative AFB smears were obtained.
The mean duration of isolation was significantly shorter in patients who had fewer than three negative AFB smears
compared to those who had three or more negative AFB smears (three days vs. five days, p <0.01). The mean cost in
patients who were de-isolated before three negative smears were obtained was USD 947 compared to USD 1,636 in
those were only de-isolated after three negative AFB smears (p <0.01).
Conclusions: Our study suggests that our institution’s current infection control policy for the isolation of patients with
suspected PTB is fairly satisfactory, but may need to be tightened further to prevent true cases of PTB being de-isolated
prematurely. However, there may be instances when patients could potentially be de-isolated more quickly without risk
to others, thus saving on the use of limited resources and costs to patients.
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Background
Tuberculosis (TB) is a major cause of morbidity and mor-
tality in many countries and a significant health problem
worldwide. According to the World Health Organization
(WHO), there were more than eight million new cases of
TB and approximately 1.4 million deaths due to TB in the
year 2011 alone [1]. The incidence rate of TB in Singapore
was 6 cases per 100,000 resident population, with over
1600 new cases being reported in 2011 [2]. Although this
incidence is the lowest in South-East Asia, it is still sev-
eral times higher than that in the United States, Western
Europe and Australia. Moreover, the incidence of TB in
Singapore has been rising since 2008 [3].
Protocols for the isolation of patients with suspected
PTB are among the most effective control measures for
the prevention of nosocomial transmission of this disease
[4]. The AFB smear often provides the first bacteriologic
evidence of mycobacterium in a clinical specimen. In
addition, smear-positive PTB is deemed more contagious
than smear negative PTB [5]. As such, AFB smears of
respiratory samples are used by most healthcare facil-
ities to determine when patients with suspected PTB
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can be removed from isolation. Isolation however, has
been shown to impede patient care and negatively im-
pact patient satisfaction [6]. There are also additional
costs of personal protective equipment, operation of
negative pressure rooms and nursing time [7].
Our hospital has 43 dedicated negative-pressure single-
bedded rooms for the isolation of patients with airborne
diseases, including those with suspected PTB. In our insti-
tution, there is no specific guideline to define such pa-
tients, and the decision to isolate is left to the discretion of
the managing physician. This often, but not always in-
cludes patients (both immunocompetent and immuno-
compromised, or suspected to be immunocompromised)
with chronic respiratory and/or constitutional symptoms
such as prolonged cough and loss of weight, and those
with chest radiograph findings suspicious of active PTB.
Although our institution does not have specific guidelines
to determine which patients are at risk for suspected PTB
and require isolation, once a decision has been made by
the managing physician to isolate a patient, our infection
control policy requires them to remain in isolation till
three consecutive respiratory samples have been shown to
be smear-negative for AFB. For this purpose, spontan-
eously expectorated sputum, laryngeal swabs and naso-
gastric aspirates are obtained from these patients. This is
extrapolated from recommendations by the Centers for
Disease Control and Prevention and the American Thor-
acic Society to test three expectorated sputa for mycobac-
terial culture to exclude infectious TB [8,9]. These samples
however, can take several days to obtain, especially if the
patient is unable to co-operate or expectorate spontan-
eously. The quality of the samples obtained may be sub-
optimal, leading to reduced diagnostic sensitivity. In some
centers, sputum induction has been adopted successfully
for increasing the diagnostic yield of PTB. Sputum induc-
tion however, may be associated with increased operating
costs as it requires special equipment, a dedicated isola-
tion room and trained nurses or physiotherapists to obtain
good quality specimens.
The main objective of this retrospective study was to
evaluate the timeliness to de-isolation of patients with
AFB smear negative respiratory samples. In particular we
wanted to assess the excess time AFB smear-negative pa-
tients spent in our isolation facility. We hypothesized that
AFB smear-negative patients were often kept in isolation
rooms longer than necessary. This would subsequently
lead to increased hospitalization cost and further stretch
the capacity of limited isolation resources.
Methods
Settings
The study was carried out in a single institution in
Singapore, which is a large 1500 bedded tertiary hospital
with over 70,000 patients admitted each year. It has 43
dedicated negative-pressure single-bedded rooms for the
isolation of patients with airborne diseases, including
those with suspected PTB.
Study design
This study was conducted as a retrospective review.
Study population
Patients were included if they met the following criteria:
1. Isolated for suspected PTB between 1st January and
31st December 2010.
2. At least one negative respiratory AFB smear result
in the same period.
Patients were excluded if they met the following criteria:
1. Any positive respiratory AFB smear result between
1st January and 31st December 2010.
All patients had respiratory samples (spontaneously ex-
pectorated sputum, laryngeal swabs, early morning naso-
gastric aspirates or broncho-alveolar lavage samples [BAL])
obtained for fluorochrome and Ziehl-Neelsen staining as
well as Mycobacterium tuberculosis (M tuberculosis) cul-
tures. In our institution, there is no specific algorithm for
testing, but in general, spontaneously expectorated sputum
collection would be attempted at the first instance. If the
patient was unable to co-operate or expectorate, then laryn-
geal swabs or naso-gastric aspirates would be collected.
Patients who were unable to expectorate or co-operate with
laryngeal swab or naso-gastric aspirate collection could
undergo bronchoscopy to obtain BAL samples according to
their managing physician’s preference. A selected number
of patients also had respiratory samples evaluated for M
tuberculosis using polymerase chain reaction (PCR) by the
ProbeTec ET DTB assay (Becton-Dickson) at individual
physician discretion. Patients would be de-isolated as per
institutional protocol if they had three AFB smear negative
respiratory samples. In patients with smear positive sam-
ples, anti-tuberculous therapy would be commenced and
they would remain in isolation for the first two weeks of
treatment or until they were discharged home, whichever
occurred sooner.
Selection of study participants
Case records of all patients who were isolated for sus-
pected PTB between 1st January and 31st December
2010 were reviewed. Of these 202 patients, 121 fit our
case definition (Figure 1).
Study variables
Demographic, clinical and radiological data were col-
lected. We analyzed the time spent in isolation, the total
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number of respiratory samples that were collected for
each patient and the time taken from collection of the
first respiratory sample to release of the result of third
AFB smear. We also analyzed the AFB smear- negative
patients whose respiratory samples were subsequently
positive for M tuberculosis by culture or molecular test-
ing. As the charges for staying in an isolation ward com-
pared to a general ward were greater (USD 290 per day
versus USD 260 per day respectively), the cost of each
isolation ward stay per patient was also calculated.
Study investigators
All the case notes were reviewed and analyzed by the
authors.
Ethics approval
Our research was carried out in compliance with the
Helsinki Declaration and approval was obtained from our
local ethics committee (Singhealth Centralised Institutional
Review Board, Reference No: 2013/559/E).
Analysis plan
A descriptive analysis was performed. Categorical data
were described in percentage and numbers. Mean, median
and independent sample T-test was used for continuous
variables, while the Chi-squared or Fisher’s exact test was




A total of 121 patients with smear negative respiratory
samples were evaluated. Their median age was 62 years.
Seventy-eight percent (n = 94) of the subjects were male.
Ten percent (n = 12) were foreigners. The majority of
subjects lived in high rise public housing (n = 102, 84%),
Figure 1 Flow diagram of patients with AFB smear-negative samples.
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with only three percent (n = 4) living in institutions or
dormitories. Nine percent (n = 11) of patients had no
fixed abode. Thirty-one percent (n = 38) of the subjects
were unemployed while 9.1% (n = 11) were unskilled la-
borers (Table 1).
Clinical and radiological data
Of the 121 patients, almost a quarter (n = 27) had a
prior history of TB. Sixty percent (n = 73) were lifetime
non-smokers. Two–thirds of patients (n = 79) had co-
morbidities such as hypertension, diabetes mellitus, hyper-
lipidemia, ischemic heart disease, renal failure, malignancy
or chronic lung disease. Twenty percent of these patients
had three or more co-morbidities. Hypertension was the
most common co-morbidity, followed by diabetes melli-
tus. Six patients were infected with HIV (Table 2).
Ninety percent of patients who were isolated were
symptomatic – with more than half of these patients suf-
fering from chronic cough or fever. Other symptoms in-
cluded anorexia (27%), loss of weight (16.3%), dyspnea
(13.8%) and hemoptysis (7.6%) (Table 2).
The median duration patients were symptomatic for any
of the following: cough, fever, anorexia, loss of weight, dys-
pnea and hemoptysis, was two weeks (mean: 46 days,
range: 1–365 days). Ninety-six percent of patients had an
abnormal chest radiograph. The most common abnormal-
ity being consolidation in two-thirds (n = 40). Nodules
were present in 17% (n = 21) and 37.2% (n = 45) had other
abnormalities such as pleural effusion, interstitial infiltrates,
granuloma, and mass lesions. Less than ten percent of pa-
tients had cavitatory lesions. Twelve percent (n = 15) of ra-
diographs were reported as showing radiological changes
suspicious of active PTB (Table 2).
Management and diagnosis
There were a total of 376 respiratory specimens collected
from 121 patients. The most common respiratory sample
obtained was sputum (63%), followed by laryngeal swabs
(20%), BAL specimens (10%) and naso-gastric aspirates
(7%). The mean and median number of smears for each
patient was three. Thirty-six patients (30%) had four or
more smears performed despite hospital protocol requir-
ing only three samples. Twenty-four patients (20%) were
de-isolated prematurely before the results of three nega-
tive AFB smears were obtained (Figure 1).
As to be expected, the mean duration of isolation was
significantly shorter in patients who had fewer than
three negative smears compared to those who had three




Median (range) 62 (16–88)
Sex – no. (%)
Male Residency – no. (%) 94 (77.6))
Singapore Residents 109 (90)
Foreigners/Immigrants 12 (10)
Type of Housing – no. (%)
Public housing 102 (84.3)
Private Housing 4 (3.3)
Institutions or dormitories 4 (3.3)
No fixed abode 11 (9.1)
Occupation – no. (%)
Unemployed 38 (31.4)
Managerial/Professional 5 (4.1)
Skilled Labor (Non-managerial/professional) 10 (8.3)
Unskilled labor 11 (9.1)
Unknown 50 (41.3)
Others 7 (5.8)
Table 2 Clinical and radiological characteristics of 121
patients with AFB smear negative respiratory samples
Characteristics
Co-morbidities – no. (%#)
Previous history of TB 27 (22.3)
Current or ex-smoker 48 (40)
Hypertension 28 (23.1)
Diabetes mellitus 23 (19)
Hyperlipidemia 19 (16.1)
Ischemic heart disease 15 (12.4)
Renal failure 13 (10.7)
Chronic lung disease 4 (3.3)
Malignancy 12 (9.9)
HIV 6 (4.9)




Loss of weight 20 (16.3)
Dyspnea 17 (13.8)
Hemoptysis 9 (7.6)
Radiological Findings – no.(%#)




Other abnormality* 45 (37.2)
TB = tuberculosis, HIV = human immunodeficiency virus.
#percentages do not add up to 100% as each patient may have more than
one co-morbidity, presenting symptom or abnormal radiological finding.
*includes granuloma, pleural effusion and mass lesions.
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or more negative smears (three days vs. five days, p <0.01).
The overall mean cost of isolation to each patient was
USD 1,440 (range: USD 290 - USD 5,510). The mean cost
in patients who were de-isolated before three negative
smears were obtained was USD 947 compared to USD
1,636 in those were only de-isolated after three negative
smears (p <0.01).
Of the patients who followed hospital protocol requiring
at least three negative smears before de-isolation, the
mean duration from collection of the first smear to report-
ing of the third negative smear was 3.8 days (median:
3 days, range: 0–22 days). On average, the time taken from
result of the third negative smear to de-isolation was
2.2 days but could range from as short as 0 to as long as
11 days. Thirty-two patients (26.4%) remained in isolation
for more than 24 hours after the result of the third nega-
tive smear was made available.
A total of 20 out of 121 patients (16.5%) were subse-
quently diagnosed with PTB based on positive culture re-
sults for M tuberculosis, despite having AFB smear-negative
respiratory samples. Half of these were from sputum sam-
ples, 35% from BAL fluid while the remaining 15% were
from naso-gastric aspirate or laryngeal swabs (Figure 1).
Thirteen patients (10.7%) had PCR for M tuberculosis
performed on their sputum or BAL samples at their
managing physician’s discretion. Of these 13, four had
positive PCR results (only two of these four patients sub-
sequently had cultures that returned positive for TB).
Of the 20 patients who had positive TB culture results,
19 (95%) were symptomatic for cough, fever, hemoptysis,
dyspnea, anorexia or loss of weight. This was compared
to 88% (n = 89) of patients in the group who were cul-
ture negative. The difference however was not statisti-
cally significant. The median duration of symptoms was
21 days in the culture positive group and 14 days in the
culture negative group (p = 0.634). Twenty-five percent
(n = 5) of culture positive patients had chest radiographs
reported as being suspicious for active TB compared
with ten percent (n = 10) of culture negative patients al-
though this difference was not statistically significant.
The mean duration of hospitalization was longer in pa-
tients with a positive culture although this did not reach
statistical significance (18.4 versus 11.6 days, p = 0.057).
The mean cost incurred from utilization of isolation
beds was significantly greater in those with a positive
culture compared to those who were culture negative
(USD 2624 versus USD 1727, p < 0.01) (Table 3). This
cost was computed directly from cost per day per room
multiplied by total days spent in isolation room per
patient.
Of the 24 patients who were de-isolated prematurely,
three patients were subsequently diagnosed with PTB
based on positive TB culture, giving an incidence of
12.5% TB positivity rate compared to 17.5% in the group
who were de-isolated only after three negative AFB smears.
None of the three patients had chest radiograph findings
suspicious of active PTB.
Three patients died during their stay in isolation. All
three patients had been diagnosed with PTB but none of
the deaths were directly attributed to PTB.
Discussion
In this study, we evaluated the efficiency of our hospital’s
current protocol for isolating and de-isolating patients
with suspected PTB. In particular, we assessed both the
timeliness of de-isolating patients who were AFB smear-
negative, as well as the effectiveness of resource utilization
by evaluating the direct hospitalization cost only.
Based on CDC guidelines, our institution’s infection
control policy requires patients to have at least three nega-
tive sputum AFB smears before they can be de-isolated
[8]. Our study found that 20% (n = 24) of patients were
de-isolated prematurely before three negative AFB smears
were obtained. None of these patients had chest radio-
graph features suggestive of PTB and only three patients
of these 24 (12.5%) were subsequently found to have cul-
ture positive PTB. To our knowledge, there have been at
least three studies which have examined the sensitivity of
consecutive smears. Nelson et al. [10] found that only 13%
of the third samples were positive when the first two
smears were negative, while Siddiqui et al. [11] reported a
similar rate of 11%. A meta-analysis by Burken et al. [12]
concluded that the sensitivity of two AFB smears was the
same as that of three AFB smears for the diagnosis of
Table 3 Comparison of TB culture positive and culture negative patients
Positive TB Culture (N = 20) Negative TB Culture (N = 101) p-value
Mean Age – yr 58.4 60.9 0.525
Symptomatic* - no. (%) 19 (95) 89 (88.1) 0.692
Median symptom duration - days 21 14 0.634
CXR suggestive of active TB – no. (%) 5 (25) 10 (10) 0.129
Mean length of hospitalization - days 18.4 11.6 0.057
Mean cost of stay in isolation ward - USD 2624 1727 <0.01
CXR = chest radiograph, TB = tuberculosis.
*includes cough, fever, anorexia, loss of weight, dyspnea and hemoptysis.
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PTB. There have also been studies which suggested that
pre-test probability of PTB may be determined by evaluat-
ing risk factors [13-15]. A systematic review by Wisnivesky
et al. [16] likewise suggested prediction rules incorporating
risk factors such as chronic symptoms, fever and upper
lobe abnormalities on chest radiograph to identify those
with a low risk of PTB. The findings from our study, to-
gether with evidence from others, suggests that it is safe to
de-isolate patients once two negative smears are obtained,
especially if the patient’s pre-test probability for PTB is
low. In our study we found that the financial cost to pa-
tients was less in those who were de-isolated before three
negative AFB smears, compared to those who were only
de-isolated after three negative AFB smears were obtained.
It is perhaps not unreasonable to consider earlier de-
isolation to strike a right balance between the need for
isolation to protect public health interests and early de-
isolation for low risk patients to optimize scarce isolation
resources. Such a measure may also potentially translate
into cost savings for individual patients without comprom-
ising public health at large. In our country where health-
care cost is mainly borne by the individual, such cost
reductions would substantially reduce out-of-pocket ex-
penses for the patient. We do note however that our cal-
culation of the cost of isolation only included isolation bed
charges and did not take into account other costs such as
charges for human resources and indirect costs. This is a
limitation of the retrospective nature of our study. It is
highly conceivable that the true cost is much higher than
reported in this study.
A third of patients in our study were only de-isolated
after four or more negative AFB smears were obtained.
Results from previous studies have shown that sensitivity
of diagnosing PTB beyond three negative AFB smears is
not increased [11,12,16]. Thus, in one-third of our pa-
tients, there was unnecessary usage of limited resources
and extra cost incurred through additional testing. We
did not specifically analyze the reasons for these extra
tests. However we postulate that this may have been a
result of communication between healthcare workers
and/or a lack of co-ordination in the handling of sam-
ples. Further efforts to improve intra-hospital work pro-
cesses so as to reduce wastage should be considered in
view of our findings.
CDC guidelines estimate that it should take no longer
than two days to safely de-isolate a patient following
their protocol. We found however that the average time
taken from obtaining the results of three negative AFB
smears to de-isolation of our patients took at least five
days. Many others have looked at the utility of induced
sputum to reduce time needed for collection of three
AFB smears samples [17,18]. Inducing sputum allows all
three samples to be collected within 24 hours, inde-
pendent of patient’s ability to expectorate. A patient’s
isolation ward stay could potentially be reduced to one
day. Compared to the extra cost of isolation stay of be-
tween USD 30 and USD 570 for a patient using our
current protocol for respiratory sample collection, in-
duced sputum would potentially translate into direct
cost savings of up to USD 540. This cost saving remains
even after factoring the extra charge of USD 40 for the
procedure. Our institution is currently in the process of
setting up such a service and we anticipate that such a
service would greatly reduce time from sputum collec-
tion to safe de-isolation.
Conclusions
Our study suggests that our institution’s current infec-
tion control policy for the isolation of patients with sus-
pected PTB is fairly satisfactory, but may need to be
tightened further to prevent true cases of PTB being de-
isolated prematurely. However, there may be instances
when patients could potentially be de-isolated more
quickly without risk to others, thus saving on the use of
limited resources. We predict that the implementation
of our sputum induction service will aid in more rapid
de-isolation of patients.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SK participated in the design of the study, collected the data and drafted the
manuscript. JMMT performed the statistical analysis. BHT provided overall
guidance and helped review the manuscript. JGHL helped in conception of
the study, participated in the study design and helped draft the manuscript.
All authors read and approved the final manuscript.
Author details
1Department of Infectious Diseases, Singapore General Hospital, 20 College
Road, Singapore 169856, Singapore. 2Department of Internal Medicine,
Singapore General Hospital, 20 College Road, Singapore 169856, Singapore.
Received: 24 June 2013 Accepted: 7 October 2014
References
1. World Health Organization: Global tuberculosis control. 2012,
[http://www.who.int/tb/publications/global_report/en/].
2. World Health Organization: Tuberculosis country profiles: Singapore. 2012,
[http://www.who.int/tb/country/data/profiles/en].
3. Cutter J, Wang YT: Tuberculosis – an underappreciated disease. Ann Acad
Med 2010, 39:261–262.
4. LoBue PA, Catanzaro A: Effectiveness of a nosocomial tuberculosis control
program at an urban teaching hospital. Chest 1998, 113:1184–1189.
5. Sepkowitz KA: How contagious is tuberculosis? Clin Infect Dis 1996,
23:954–962.
6. Kelly-Rossini L, Perlman DC, Mason DJ: The experience of respiratory
isolation for HIV-infected persons with tuberculosis. J Assoc Nurses AIDS
Care 1996, 7:29–36.
7. Wilmer A, Bryce E, Grant J: The role of third acid-fast bacillus smear in
tuberculosis screening for infection control purposes: a controversial
topic revisited. Can J Infect Dis Med Microbiol 2011, 22(1):e1–e3.
8. Centers for Disease Control and Prevention: Guidelines for preventing the
transmission of mycobacterium tuberculosis in health-care settings,
2005. MMWR 2005, 54(RR-17):1–141.
9. Bass JB, Farer LS, Hopewell PC, Jacobs RF, Snider DE: Diagnostic standards
and classification of tuberculosis. Ann Rev Respir Dis 1990, 149:1359–1374.
Kalimuddin et al. BMC Infectious Diseases 2014, 14:547 Page 6 of 7
http://www.biomedcentral.com/1471-2334/14/547
10. Nelson SM, Deike MA, Cartwright CP: Value of examining multiple sputum
specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol
1998, 36:467–469.
11. Siddiqui AH, Perl TM, Conlon M, Donegan N, Roghmann M: Preventing
nosocomial transmission of pulmonary tuberculosis: when may isolation
be discontinued for patients with suspected tuberculosis? Infect Control
Hosp Epidemiol 2002, 23:141–144.
12. Burken MI, Shea JA, Johnson CC, Hershey JC, Asch DA: Comparison of
sputum microscopy versus nucleic acid amplification for the
presumptive diagnosis of pulmonary tuberculosis: a meta-analysis.
Clin Performance Qual Health Care 1998, 6:53–59.
13. Wisnivesky JP, Henschke C, Balentine J, Wilner C, Delorie A, McGinn T:
Prospective validation of a prediction rule to assess the need for
respiratory isolation for inpatients with suspected tuberculosis.
Arch Intern Med 2005, 165:453–457.
14. Wisnivesky JP, Kaplan J, Henschke C, McGinn T, Crystal RG: Evaluation of
clinical parameters to predict Mycobacterium tuberculosis in inpatients.
Arch Inter Med 2000, 160:2471–2476.
15. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E: The validity of
medical history, classic symptoms, and chest radiographs in predicting
pulmonary tuberculosis: derivation of a pulmonary tuberculosis
prediction model. Chest 1999, 115:1248–1253.
16. Wisnivesky JP, Serebrisky D, Moore C, Sacks H, Iannuzzi MC, McGinn T:
Validity of clinical prediction rules for isolating in patients with
suspected tuberculosis – a systematic review. J Gen Int Med 2005,
20:947–952.
17. Li LM, Bai LQ, Yang HL, Xiao CF, Tang RY, Chen YF, Chen SM, Liu SS, Zhang
SN, Ou YH, Niu TI: Sputum induction to improve the diagnostic yield in
patients with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis
1999, 3:1137–1139.
18. Al Zahrani K, Al Jahdali H, Poirier L, René P, Menzies D: Yield of smear,
culture and amplification tests from repeated sputum induction for the
diagnosis of pulmonary tuberculosis. Int J Tuberc Lung Dis 2001,
5:855–860.
doi:10.1186/s12879-014-0547-7
Cite this article as: Kalimuddin et al.: A retrospective review of a tertiary
Hospital’s isolation and de-isolation policy for suspected pulmonary
tuberculosis. BMC Infectious Diseases 2014 14:547.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Kalimuddin et al. BMC Infectious Diseases 2014, 14:547 Page 7 of 7
http://www.biomedcentral.com/1471-2334/14/547
